{ "source_attachment": { "filename": "serenitol_1(3).jpg", "path": "" }, "document": { "title_or_product": "SereniTol", "summary": "A promotional advertisement for SereniTol, presented as a natural mood-support supplement and shown alongside Holland & Barrett branding. The advertisement promises improved mood, calmness and stress reduction, claims scientifically proven effects on neurotransmitter balance, and reports that 85% of users felt more relaxed and positive after four weeks. It features a smiling woman holding the product. The principal concerns are insufficiently substantiated efficacy claims, an imprecise biological mechanism presented as scientifically proven, and an unverifiable numerical consumer-trial result." }, "marks": [ { "id": "m01", "description": "Several mutually reinforcing statements present SereniTol as effective at improving mood and reducing stress. The headline, benefit statements and smiling product-holder combine to create a favourable impression of emotional improvement attributable to the supplement. These are recognisable wellbeing claims, not inherently implausible, but the advertisement provides no identifiable product-specific evidence demonstrating that the complete formulation produces these benefits. The claim to reduce stress and tension is particularly definite. Depending on the product classification and market, the wording may also require review under applicable health-claims rules.", "locations": [ { "text": "Natural support for inner", "bbox": [0.042, 0.324, 0.479, 0.393] }, { "text": "calm and a positive outlook.", "bbox": [0.042, 0.407, 0.528, 0.475] }, { "text": "Supports balanced mood", "bbox": [0.083, 0.561, 0.345, 0.612] }, { "text": "Reduces stress & tension", "bbox": [0.083, 0.642, 0.35, 0.695] }, { "text": "Discover your brighter", "bbox": [0.042, 0.077, 0.589, 0.178] }, { "text": "side with SereniTol.", "bbox": [0.042, 0.191, 0.521, 0.291] }, { "text": "", "bbox": [0.612, 0.047, 0.767, 0.433] } ], "assessments": [ { "field": "TATD", "score": 0.76, "reason": "The advertisement presents several specific product benefits, including reduction of stress and tension, without identifying supporting studies, the tested formulation, dosage or measured effects. The separate consumer-trial statistic cannot by itself establish these benefits." }, { "field": "VP", "score": 0.58, "reason": "The brighter-side headline, promises of a positive outlook, smiling woman and prominent product presentation reinforce an appealing image of emotional wellbeing. The imagery is ordinary advertising imagery, but strengthens the benefit impression created by the unsubstantiated claims." } ], "recommendation": "Check the mood and stress claims against reliable evidence for the marketed formulation at its recommended dose. Qualify or remove benefits that exceed the evidence, and verify that the resulting wording is permissible under the health-claims rules applicable to the intended market. The positive lifestyle photograph need not be removed merely because it depicts a happy person.", "revised_text": "" }, { "id": "m02", "description": "The advertisement declares that the product is scientifically proven to promote natural neurotransmitter balance and thereby help regulate mood and stress responses. 'Natural neurotransmitter balance' is not defined as a particular measurable physiological endpoint. No neurotransmitter, biological pathway, experimental measurement or supporting study is identified. The adjacent reference to standardized extracts adds an impression of pharmaceutical precision without specifying which extracts are standardized, to what constituents or concentrations, or whether evidence for the ingredients transfers to the finished product. Together, the statements present an inadequately explained biological mechanism as established science.", "locations": [ { "text": "Scientifically proven to promote natural neurotransmitter", "bbox": [0.043, 0.807, 0.491, 0.842] }, { "text": "balance, helping your body regulate mood and stress responses.", "bbox": [0.043, 0.844, 0.51, 0.879] }, { "text": "Formulated with standardized extracts", "bbox": [0.083, 0.722, 0.476, 0.774] } ], "assessments": [ { "field": "SD", "score": 0.53, "reason": "The wording suggests that mood and stress regulation can be explained through a general, identifiable state of neurotransmitter balance which the product promotes. This oversimplifies complex neurobiological regulation and implies a defined causal mechanism without specifying one. The concern is misleading mechanistic framing, not proof that the product has no neurological effects." }, { "field": "TATD", "score": 0.94, "reason": "The categorical assertion 'Scientifically proven' is unsupported by an identifiable study. There is no information about the tested preparation, relevant doses, biochemical measurements, study design or whether the proposed mechanism was demonstrated in humans. Ingredient standardization is also unspecified." }, { "field": "CD", "score": 0.88, "reason": "'Natural neurotransmitter balance' borrows legitimate neurochemical terminology without defining what is balanced or how that state would be measured. Combined with 'Scientifically proven' and 'standardized extracts', it creates an impression of established scientific precision that the advertisement does not substantiate." } ], "recommendation": "Require evidence specifically supporting the proposed physiological mechanism in the marketed formulation. Identify the relevant neurotransmitters, measured endpoints, effective dose and studies if they exist. Clarify the extract identities and standardization specifications where they are material to the claim. Otherwise remove the assertion of scientific proof and the undefined neurotransmitter-balance explanation rather than replacing them with another speculative mechanism.", "revised_text": "" }, { "id": "m03", "description": "The advertisement reports that 85% of users experienced a noticeable improvement in relaxation and positivity within four weeks, attributing the figure to 'consumer trials'. The precise percentage suggests quantitative reliability, but no study or survey is identified. The number of participants, recruitment process, questionnaire, baseline measurements, comparator, treatment adherence and statistical uncertainty are unknown. It is also unclear whether the reported percentage represents all enrolled participants, those completing the trial, or a selected group of respondents. The wording correctly identifies the result as self-reported, but the surrounding assertions of scientifically proven effectiveness may encourage readers to interpret it as controlled evidence of product efficacy.", "locations": [ { "text": "In consumer trials, 85% of users reported feeling noticeably", "bbox": [0.043, 0.898, 0.496, 0.938] }, { "text": "more relaxed and positive within just four weeks of daily use.", "bbox": [0.043, 0.94, 0.504, 0.978] }, { "text": "Scientifically proven to promote natural neurotransmitter", "bbox": [0.043, 0.807, 0.491, 0.842] } ], "assessments": [ { "field": "TATD", "score": 0.97, "reason": "A prominent and precise numerical outcome is presented without a traceable source or the methodological information required to evaluate it. The term 'consumer trials' does not establish the rigour of the investigation. Without a comparator or suitable study design, self-reported improvement cannot reliably establish that the supplement caused the change." } ], "recommendation": "Provide an identifiable source and enough methodological information to verify the 85% figure, including sample size, eligibility criteria, exact question and response options, denominator, study duration, withdrawals, comparator if any, and uncertainty where appropriate. Establish whether the underlying evidence is a consumer-satisfaction survey, an uncontrolled user study or a controlled trial. If adequately supported, describe the result using terminology faithful to the actual study design; otherwise remove the percentage and four-week efficacy implication.", "revised_text": "" } ] }